Hospira Benelux SRL
Hospira Benelux reported total assets of €3.95m at the end of the 2025 financial year (annual accounts filed with the NBB on 02 Jun 2026).
By total assets for 2025, Hospira Benelux ranks in the top half of the 970 companies in its sector (NACE 4646) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Hospira Benelux shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +6 % Total assets +6 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Hospira Benelux's annual accounts
Filed annual accounts
- Year ended 30 Nov 2025filed on 02 Jun 2026
- Year ended 30 Nov 2024filed on 26 May 2025
- Year ended 30 Nov 2023filed on 21 May 2024
- Year ended 30 Nov 2022filed on 23 May 2023
- Year ended 30 Nov 2021filed on 01 Jun 2022
Hospira Benelux's financial analysis
- Solvency99.9%sector median: 33.7%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Hospira Benelux
Hospira Benelux's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0449.591.040
- VAT number
- No VAT activity declared to the CBE
- Peppol
- Not found on Peppol as of 10 Nov 2026 · Check
- Legal form
- SRL
- Incorporated
- 08 Mar 1993
- Registered office
- 1050 Ixelles
- Latest accounts
- 2025 · filed on 02 Jun 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Hospira Benelux (SRL) has been based in Ixelles since 1993, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net profit of 55,842 € and equity of €3.94m; its revenue is not published. Its solvency stands at 99.9%, above the median of its sector (33.7%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Hospira Benelux
Companies in the same business, of comparable size and area, outside its group.
- Pimac Activities of holding companies Wavre · balance sheet €3.95m
- Cascara Ventures Activities of holding companies Overijse · balance sheet €3.95m
- CLCC Other information service activities Grimbergen · balance sheet €3.95m
- Liquifin International Activities of holding companies Oostkamp · balance sheet €3.95m
- Cadran Holding Activities of head offices Villers-le-Bouillet · balance sheet €3.96m
- Bombora Activities of holding companies Turnhout · balance sheet €3.94m
- Citran Greysac Activities of holding companies Lasne · balance sheet €3.94m
- Belle VUE Invest Activities of holding companies Woluwe-Saint-Pierre · balance sheet €3.94m
Frequently asked questions about Hospira Benelux
What is the revenue of Hospira Benelux?
Hospira Benelux files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Hospira Benelux?
According to the Crossroads Bank for Enterprises, no VAT-liable activity is declared for Hospira Benelux. If it is VAT-registered, its VAT number is its company number prefixed with BE: BE0449591040. Its company number (CBE) is 0449.591.040.
Where is the registered office of Hospira Benelux?
According to the CBE register, the registered office of Hospira Benelux is in 1050 Ixelles.
What is the equity of Hospira Benelux?
At the close of the 2025 financial year, the equity of Hospira Benelux amounts to 3,944,053 €, a solvency of 99.9% of total assets.
Who manages Hospira Benelux?
The register lists 2 active mandates at Hospira Benelux. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Hospira Benelux within its sector?
By total assets for 2025, Hospira Benelux ranks in the top half of the 970 companies in its sector (NACE 4646) in Belgium that filed accounts for that financial year.
The full file of Hospira Benelux
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →